Genetic risk factors for Achilles tendon injuries

International SportMed Journal

Volumn 7, Issue 3, 2006, Pages 201-215

  September, Alison V ^a   Mokone, Gaonyadiwe G ^a   Schwellnus, Martin P ^a   Collins, Malcolm ^a,b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^c UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Chromosome 9; COL5A1; Collagen; Injury; Overuse; Tenascin; TNC

Indexed keywords

EID: 34248562879     PISSN: None     EISSN: 15283356     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. McGinnis JM. The public health burden of a sedentary lifestyle. Med Sci Sports Exerc 1992;24:S196-S200.
2. Jarvinen TA, Kannus P, Maffulli N, et al. Achilles tendon disorders: Etiology and epidemiology. Foot Ankle Clin 2005;10:255-266.
3. Mazzone MF,.McCue T. Common conditions of the Achilles tendon. Am Fam Physician 2002;65:1805-1810.
4. Khan KM, Cook JL, Bonar F, et al. Histopathology of common tendinopathies. Updates and implications for clinical managment. Sports Med 1999;27:393-408.
5. Puddu G, Ippolito E, Postacchini F. A classification of Achilles tendon disease. Am J Sports Med 1976;4:145-150.
6. Almekinders LC. Tendinitis and other chronic tendinopathies. J Am Acad Orthop Surg 1998;6:157-164.
7. Schepsis AA, Jones H, Haas AL. Achilles tendon disorders in athletes. Am.J.Sports Med 2002;30:287-305.
8. Kannus P, Jarvinen TL, Jarvinen TA, et al. Painful Achilles tendon and its treatment. Scand J Med Sci Sports 2004;14:69-71.
9. Riley G. The pathogenesis of tendinopathy: A molecular perspective. Rheumatology 2004;43:131-142.
10. Rees JD, Wilson AM, Wolman RL. Current concepts in the management of tendon disorders. Rheumatology 2006;45:508-521.
11. Jozsa L, Kvist M, Balint BJ, et al. The role of recreational sport activity in Achilles tendon rupture: A clinical, pathoanatomical, and sociological study of 292 cases. Am J Sports Med 1989;17:338-342.
12. Kvist M. Achilles tendon injuries in athletes. Sports Med 1994;18:173-201.
13. Ekstrand J,.Nigg BM. Surface-related injuries in soccer. Sports Med 1989;8:56-62.
14. Jozsa L, Kannus P. Human tendons: Anatomy, physiology, and pathology. Human Kinetics, 1997.
15. Safra MR,.Graham SM. Distal biceps tendon ruptures: Incidence, demographics, and the effect of smoking. Clin Orthop Relat Res 2002;(404);275-283.
16. Harris SB, Harris D, Foster AJ, et al. The aetiology of acute rupture of flexor tendon repairs in zones 1 and 2 of the fingers during early mobilization. J Hand Surg [Br] 1999;24:275-280.
17. van der Linden PD, Nab HW, Simonian S, et al. Fluoroquinolone use and the change in incidence of tendon ruptures in the Netherlands. Pharm World Sci 2001;23:89-92.
18. Shrier I, Matheson GO, Kohl HW, III. Achilles tendonitis: Are corticosteroid injections useful or harmful? Clin J Sport Med 1996;6:245-250.
19. Inhofe PD, Grana WA, Egle D, et al. The effects of anabolic steroids on rat tendon: An ultrastructural, biomechanical, and biochemical analysis. Am J Sports Med 1995;23:227-232.
20. Gilcreest EL. Ruptures and tears of muscles and tendons of the lower extremity: Report of fifteen cases. JAMA 1933;100:153-160.
21. Schmidt-Rohlfing B, Graf J, Schneider U, Niethard FU. The blood supply of the Achilles tendon. Int Orthop 1992;16:29-31.
22. Leppilahti J, Puranen J, Orava S. Incidence of Achilles tendon rupture. Acta Orthop Scand 1996;67:277-279.
23. Kannus P, Natri A. Etiology and pathophysiology of tendon ruptures in sports. Scand J Med Sci Sports 1997;7:107-112.
24. Fredberg U,.Bolvig L. Significance of ultrasonographically detected asymptomatic tendinosis in the patellar and achilles tendons of elite soccer players: A longitudinal study. Am J Sports Med 2002;30:488-491.
25. Knobloch K, Kraemer R, Lichtenberg A, et al. Achilles tendon and paratendon microcirculation in midportion and insertional tendinopathy in athletes. Am J Sports Med 2006;34:92-97.
26. Wilson AM,.Goodship AE. Exercise-induced hyperthermia as a possible mechanism for tendon degeneration. J Biomech 1994;27:899-905.
27. Ozgurtas T, Yildiz C, Serdar M, et al. Is high concentration of serum lipids a risk factor for Achilles tendon rupture? Clin Chim Acta 2003;331:25-28.
28. Olivieri I, Gemignani G, Gherardi S, et al. Isolated HLA-B27 associated Achilles tendinitis. Ann Rheum Dis 1987;46:626-627.
29. Olivieri I, Padula A, Lisanti ME, et al. Longstanding HLA-B27 associated Achilles tendinitis. Ann Rheum Dis 1992;51:1265.
30. Harvie P, Ostlere SJ, Teh J, et al. Genetic influences in the aetiology of tears of the rotator cuff: Sibling risk of a full-thickness tear. J Bone Joint Surg Br 2004;86:696-700.
31. Flynn RK, Pedersen CL, Birmingham TB, et al. The familial predisposition toward tearing the anterior cruciate ligament: A case control study. Am.J.Sports Med 2005;33:23-28.
32. De Paepe A, Nuytinck L, Hausser I, et al. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos Syndromes I and II. Am.J.Hum.Genet. 1997;60:547-554.
33. Prockop DJ, Chu ML, de Wet W, et al. Mutations in osteogenesis imperfecta leading to the synthesis of abnormal type I procollagens. Ann N Y Acad Sci 1985;460:289-297.
34. Sharma P,.Maffulli N. Tendon injury and tendinopathy: Healing and repair. J Bone Joint Surg Am 2005;87:187-202.
35. Hunter DJ. Gene-environment interactions in human diseases. Nat Rev Genet 2005;6:287-98.
36. Ala-Kokko L. Genetic risk factors for lumbar disc disease. Ann Med 2002;34:42-47.
37. Tilkeridis C, Bei T, Garantziotis S, et al. Association of a COL1A1 polymorphism with lumbar disc disease in young military recruits. J Med Genet 2005;42:e44.
38. Noponen-Hietala N, Kyllonen E, Mannikko M, et al. Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann Rheum Dis 2003;62:1208-1214.
39. Solovieva S, Kouhia S, Leino-Arjas P, et al. Interleukin 1 polymorphisms and intervertebral disc degeneration. Epidemiology 2004;15:626-633.
40. Solovieva S, Lohiniva J, Leino-Arjas P, et al. COL9A3 gene polymorphism and obesity in intervertebral disc degeneration of the lumbar spine: evidence of gene-environment interaction. Spine 2002;27:2691-2696.
41. Lander ES, Linton LM, Birren B, et al. Initial sequencing and analysis of the human genome. Nature 2001;409:860-921.
42. Venter JC, Adams MD, Myers EW, et al. The sequence of the human genome. Science 2001;291:1304-1351.
43. Sachidanandam R, Weissman D, Schmidt SC, et al. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature 2001;409:928-933.
44. The International HapMap Consortium. A haplotype map of the human genome. Nature 2005;437:1299-1320.
45. Kruglyak L,.Nickerson DA. Variation is the spice of life. Nat Genet 2001;27:234-236.
46. Hattersley AT,.McCarthy MI. What makes a good genetic association study? Lancet 2005;366:1315-1323.
47. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H pollymorphism in age-related macular degeneration. Science 2005;308:385-389.
48. Hirschhorn JN,.Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet 2005;6:95-108.
49. Lowe CE, Cooper JD, Chapman JM, et al. Cost-effective analysis of candidate genes using htSNPs: A staged approach. Genes Immun 2004;5:301-305.
50. Jozsa L, Balint JB, Kannus P, et al. Distribution of blood groups in patients with tendon rupture. J Bone Joint Surg Br 1989;71-B:272-274.
51. Kujala UM, Jarvinen M, Natri A, et al. ABO blood groups and musculoskeletal injuries. Injury 1992;23:131-133.
52. Aroen A, Helgo D, Granlund OG, et al. Contralateral tendon rupture risk is increased in individuals with a previous Achilles tendon rupture. Scand J Med Sci Sports 2004;14:30-33.
53. Leppilahti J, Puranen J, Orava S. ABO blood group and Achilles tendon rupture. Ann Chir Gynaecol 1996;85:369-371.
54. Mahrlein R, Schmelzeisen H, Papathanassopoulos A. Achillessehnenrupturen und blutgruppenzugehorigkeit [In German]. Aktuelle Traumatol 1995; 25, 13-15.
55. Maffulli N, Reaper JA, Waterston SW, et al. ABO blood groups and Achilles tendon rupture in the Grampian Region of Scotland. Clin J Sport Med 2000;10:269-271.
56. Mokone GG. Risk-factors for Achilles tendon injuries: An emphasis on the identification of specific genetic factors. Unpublished thesis. University of Cape Town. 2006.
57. Maffulli N, Wong J, Almekinders LC. Types and epidemiology of tendinopathy. Clin Sports Med 2003;22:675-692.
58. Maffulli N,.Kader D. Tendinopathy of tendo Achillis. J Bone Joint Surg Br 2002;84:1-8.
59. Bennett EP, Steffensen R, Clausen H, et al. Genomic clonning of the human histo-blood group ABO locus. Blochem Biophys Res Commun 1995;206:18-25.
60. McIntosh I, Dunston JA, Liu L, et al. Nail patella syndrome revisited: 50 years after linkage. Ann Hum Genet 2005;69:349-363.
61. Ireland D, Harrell R, Curry V, et al. Multiple changes in gene expression in chronic human Achilles tendinopathy. Matrix Biol 2001;20:159-169.
62. Corps AN, Robinson AH, Movin T, et al. Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology 2004;43:969-972.
63. Jones GC, Corps AN, Pennington CJ, et al. Expression profiling of metalloproteinases and tissue inhibitors of metalloproteinases in normal and degenerate human Achilles tendon. Arthritis Rheum 2006;54:832-842.
64. Kannus P. Structure of the tendon connective tissue. Scand J Med Sci Sports 2000;10:312-320.
65. O'Brien M. Functional anatomy and physiology of tendons. Clin Sports Med 1992;11:505-520.
66. Yuan J, Wang MX, Murrell GA. Cell death and tendinopathy. Clin Sports Med 2003;22:693-701.
67. Riley G. Chronic tendon pathology: Molecular basis and therapeutic implications. Expert Rev Mol Med 2005;7:1-25.
68. Waggett AD, Ralphs JR, Kwan AP, et al. Characterization of collagens and proteoglycans at the insertion of the human Achilles tendon. Matrix Biol 1998;16:457-470.
69. Fukuta S, Oyama M, Kavalkovich K, et al. Identification of types II, IX and X collagens at the insertion site of the bovine achilles tendon. Matrix Biol 1998;17:65-73.
70. Myllyharju J,.Kivirikko KI. Collagens and collagen-related diseases. Ann Med 2001;33:7-21.
71. Junqueira LC, Carneiro J, Kelley RO. Basic histology. Stamford, Connecticut: Appleton & Lange, 1998.
72. Kobayashi A, Sugisaka M, Takehana K, et al. Morphological and histochemical analysis of a case of superficial digital flexor tendon injury in the horse. J Comp Pathol 1999;120:403-414.
73. Hardingham TE,.Fosang AJ. Proteoglycans: Many forms and many functions. FASEB J 1992;6:861-870.
74. Riley GP. Gene expression and matrix turnover in overused and damaged tendons. Scand J Med Sci Sports 2005;15:241-251.
75. Ameye L, Aria D, Jepsen K, et al. Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J 2002;16:673-680.
76. Jepsen KJ, Wu F, Peragallo JH, et al. A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol.Chem 2002;277:35532-35540.
77. Vij N, Roberts L, Joyce S, et al. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: Implications in the cornea. Exp Eye Res 2004;78:957-971.
78. Docheva D, Hunziker EB, et al. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 2005; 25:699-705.
79. Midwood KS,.Schwarzbauer JE. Tenascin-C modulates matrix contraction via focal adhesion kinase-and Rho-mediated signaling pathways. Mol Biol Cell 2002;13:3601-3613.
80. Sasaki T, Fassler R, Hohenester E. Laminin. The crux of basement membrane assembly. J Cell Biol 2004;164:959-963.
81. Brandau O, Meindl A, Fassler R, et al. A novel gene, tendin, is strongly expressed in tendons and ligaments and shows high homology with chondromodulin-I. Dev Dyn 2001;221:72-80.
82. Kaushal GP,.Shah SV. The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family. J Clin Invest 2000;105:1335-1337.
83. Mokone GG, Gajjar M, September AV, et al. The Guanine-thymine dinucleotide repeat polymorphism within the tenascin-C gene is associated with Achilles tendon injuries. Am J Sports Med 2005;33:1016-1021.
84. Mokone GG, Schwellnus MP, Noakes TD, et al. The COL5A1 gene and Achilles tendon pathology. Scand J Med Sci Sports 2006;16:19-26.
85. Jarvinen TA, Kannus P, Jarvinen TL, et al. Tenascin-C in the pathobiology and healing process of musculoskeletal tissue injury. Scand J Med Sci Sports 2000;10:376-382.
86. Jones FS,.Jones PL. The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling. Dev Dyn 2000;218:235-259.
87. Jarvinen TA, Jozsa L, Kannus P, et al. Mechanical loading regulates tenascin-C expression in the osteotendinous junction. J Cell Sci 1999;112 Pt 18:3157-3166.
88. Jarvinen TA, Jozsa L, Kannus P, et al. Mechanical loading regulates the expression of tenascin-C in the myotendinous junction and tendon but does not induce de novo synthesis in the skeletal muscle. J Cell Sci 2003;116:857-866.
89. Smith M,.Simpson NE. Report of the committee on the genetic constitution of chromosomes 9 and 10. Cytogenet Cell Genet 1989;51:202-225.
90. Greenspan DS, Byers MG, Eddy RL, et al. Human collagen gene COL5A1 maps to the q34.2-q34.3 region of chromosome 9, near the locus for Nail-Patella Syndrome. Genomics 1992;12:836-837.
91. Birk DE. Type V collagen: Heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001;32:223-237.
92. Birk DE, Fitch JM, Babiarz JP, et al. Collagen fibrillogenesis in vitro: Interaction of types I and V collagen regulates fibril diameter. J Cell Sci 1990;95:649-657.
93. Dressler MR, Butler DL, Wenstrup R, et al. A potential mechanism for age-related declines in patellar tendon biomechanics. J Orthop Res 2002;20:1315-1322.
94. Goncalves-Neto J, Witzel SS, Teodoro WR, et al. Changes in collagen matrix composition in human posterior tibial tendon dysfunction. Joint Bone Spine 2002;69:189-194.
95. Wenstrup RJ, Florer JB, Cole WG, et al. Reduced type I collagen utilization: A pathogenic mechanism in COL5A1 haplo-insufficient Ehlers-Danlos syndrome. J Cell Biochem 2004;92:113-124.
96. Boot-Handford RP, Tuckwell DS, Plumb DA, et al. A novel and highly conserved collagen (pro(alpha)1(XXVII)) with a unique expression pattern and unusual molecular characteristics establishes a new clade within the vertebrate fibrillar collagen family. J Biol.Chem 2003;278:31067-31077.
97. Pace JM, Corrado M, Missero C, et al. Identification, characterization and expression analysis of a new fibrillar collagen gene, COL27A1. Matrix Biol 2003;22:3-14.
98. Koch M, Olson PF, Albus A, et al. Characterization and expression of the laminin gamma3 chain: A novel, non-basement membrane-associated, laminin chain. J Cell Biol 1999;145:605-618.